Mechanisms of platelet retention in the collagen-coated-bead column (Q28166180)

1

0 references

Olga Cuyun-Lira

2

0 references

Toshiro Takafuta

3

0 references

Katsue Suzuki-Inoue

4

0 references

Kaneo Satoh

5

0 references

Kayoko Ohtsuki

6

0 references

Masatoshi Ohnishi

7

0 references

Morio Arai

8

0 references

Yutaka Yatomi

9

0 references

Yukio Ozaki

A revised model of platelet aggregation

10

0 references

language of work or name

English

0 references

publication date

October 2003

0 references

published in

Translational Research

0 references

volume

142

0 references

issue

4

0 references

page(s)

258-67

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900133-1

Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900133-1

The role of blood flow in platelet adhesion, fibrin deposition, and formation of mural thrombi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900133-1

Adhesion of platelets to subendothelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900133-1

Standardization of platelet function tests

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900133-1

A Study of Platelet Retention by Glass Bead Columns (‘Platelet Adhesiveness’ in Normal Subjects)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900133-1

In vitro assessment of platelet function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900133-1

Platelet function analyzer (PFA-100): a tool to quantify congenital or acquired platelet dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900133-1

Progress in the assessment of platelet function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900133-1

Appropriate laboratory assessment as a critical facet in the proper diagnosis and classification of von Willebrand disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900133-1

AJvW-2, an anti-vWF monoclonal antibody, inhibits enhanced platelet aggregation induced by high shear stress in platelet-rich plasma from patients with acute coronary syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900133-1

Rhodocytin induces platelet aggregation by interacting with glycoprotein Ia/IIa (GPIa/IIa, Integrin alpha 2beta 1). Involvement of GPIa/IIa-associated src and protein tyrosine phosphorylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900133-1

Identification of the collagen-binding site of the von Willebrand factor A3-domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900133-1

Platelet GPIIb/IIIa antagonists: the first anti-integrin receptor therapeutics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900133-1

Platelets with 10% of the normal amount of glycoprotein VI have an impaired response to collagen that results in a mild bleeding tendency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900133-1

Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900133-1

Involvement of glycoprotein VI in platelet thrombus formation on both collagen and von Willebrand factor surfaces under flow conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900133-1

Glycoprotein VI but not alpha2beta1 integrin is essential for platelet interaction with collagen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900133-1

Rapid and simple platelet function assay to assess glycoprotein IIb/IIIa receptor blockade.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900133-1

Application of ex vivo flow chamber system for assessment of stent thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900133-1

The blood platelet as a model for regulating blood coagulation on cell surfaces and its consequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900133-1

The effect of salicylates on the hemostatic properties of platelets in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900133-1

Platelet physiology and abnormalities of platelet function (first of two parts).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900133-1

Antiplatelet agents in stroke prevention. combination therapy: present and future

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900133-1

Inhibition by combined therapy with ticlopidine and aspirin of enhanced platelet aggregation during physical exercise in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900133-1

Effects of ticlopidine on von Willebrand factor-mediated shear-induced platelet activation and aggregation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900133-1

The P2Y12 receptor as a therapeutic target in cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900133-1

Identification of the platelet ADP receptor targeted by antithrombotic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900133-1

Identification, characterization, and inhibition of the platelet ADP receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900133-1

Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900133-1

Release of adenosine triphosphate by adenosine diphosphate in whole blood and in erythrocyte suspensions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900133-1

Identification of a 160,000 dalton platelet membrane protein that mediates the initial divalent cation-dependent adhesion of platelets to collagen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900133-1

Adhesion of human platelets to immobilized trimeric collagen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900133-1

Activation of protein-tyrosine kinase pathways in human platelets stimulated with the A1 domain of von Willebrand factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900133-1

Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900133-1

Novel methods for assessing platelet function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900133-1

Quantitative measurement of various 5-HT receptor antagonists on platelet activation induced by serotonin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900133-1

Effects of ONO-3708, an antagonist of the thromboxane A2/prostaglandin endoperoxide receptor, on platelet aggregation and thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900133-1

Role of ADP receptor P2Y(12) in platelet adhesion and thrombus formation in flowing blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900133-1

Blockade of adenosine diphosphate receptors P2Y(12) and P2Y(1) is required to inhibit platelet aggregation in whole blood under flow

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900133-1